Sheyu Li (@lisheyusheyu) 's Twitter Profile
Sheyu Li

@lisheyusheyu

Clinical diabetologist and endocrinologist in West China Hospital and Methodologist of clinical practice guideline in MAGIC China Center

ID: 739860585395802112

linkhttps://www.dundee.ac.uk/people/sheyu-li calendar_today06-06-2016 16:44:44

236 Tweet

83 Followers

90 Following

JMIR Publications (@jmirpub) 's Twitter Profile Photo

JMIR Diabetes is now indexed in #WebofScience™ & may receive its inaugural Journal Impact Factor (JIF) as early as 2025! 🎉 Thank you to our authors, reviewers & editors for contributing to this milestone. 🔗 hubs.la/Q02ZmpXV0 Ricardo Correa MD, EdD, FACP, FACE, FAPCR, FACMQ Sheyu Li

JMIR Diabetes is now indexed in #WebofScience™ & may receive its inaugural Journal Impact Factor (JIF) as early as 2025! 🎉

Thank you to our authors, reviewers & editors for contributing to this milestone.
đź”— hubs.la/Q02ZmpXV0

<a href="/drricardocorrea/">Ricardo Correa MD, EdD, FACP, FACE, FAPCR, FACMQ</a> <a href="/LisheyuSheyu/">Sheyu Li</a>
Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

New BMJ Guideline: proactive therapeutic drug monitoring of biologic drugs in adult patients with autoimmune diseases bmj.com/content/387/bm…

Cochrane (@cochranecollab) 's Twitter Profile Photo

📚 Statistical errors in meta-analyses can impact the reliability of systematic reviews. This new article highlights the most frequent mistakes and how to avoid them. 📖 Read it here: buff.ly/4jFoThH #SystematicReviews #MetaAnalysis #ResearchMethods #Statistics

📚 Statistical errors in meta-analyses can impact the reliability of systematic reviews. This new article highlights the most frequent mistakes and how to avoid them. 

đź“– Read it here: buff.ly/4jFoThH 

#SystematicReviews #MetaAnalysis #ResearchMethods #Statistics
Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

Scoping review indicates heterogeneous methods for developing and integrating patient decision aids in the context of clinical practice guidelines - Journal of Clinical Epidemiology jclinepi.com/article/S0895-…

Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

Health Technology Assessment (HTA) using real-world individual-level patient data: simulating the time-vary effect - SGLT2i for HFrEF as the example. frontiersin.org/journals/pharm…

Gordon H. Guyatt (@guyattgh) 's Twitter Profile Photo

In this 11 minute video, I discuss the findings of a recent #BMJ #SystematicReview of the use of #SGLT-2 inhibitors to prevent the progression of #KidneyDisease in patients with or without #diabetes. vimeo.com/1061221054

Farid Foroutan (@faridftn) 's Twitter Profile Photo

🤖Just out in The BMJ: Our rapid rec on the use of AI-based computer-aided detection (CADe) in colonoscopy. Using GRADE, we issue a weak recommendation against its routine use. Co-development with American Gastroenterological Association (AGA) bmj.com/content/388/bm… #AI #Colonoscopy #GRADE #BMJ

Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

Emerging digital supports as novel approaches to shift health ecosystem for perioperative patients #perioperation #diabetes #digital #decisionaid #jmir diabetes.jmir.org/2025/1/e70475

Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study bmj.com/content/389/bm…

Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

Retracted trials are contaminating evidence ecosystem, shown by VITALITY Study I #retraction #misconduct Retraction Watch bmj.com/content/389/bm…

Gordon H. Guyatt (@guyattgh) 's Twitter Profile Photo

Classic #JAMA paper using #MetaRegression to establish that stopping #RCTs early for benefit on average overestimates treatment effects by 29% and creates spurious estimates of effect up to 38% of the time. #EBM #Medicine pubmed.ncbi.nlm.nih.gov/20332404/

Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

GLP1R medications show remarkable efficacy in T2D & obesity, but inter-individual responses vary. Precision medicine & biomarkers guide treatment, though widespread screening may not be cost-effective. #Diabetes #PrecisionMedicine #GLP1R academic.oup.com/jcem/article/1…

GLP1R medications show remarkable efficacy in T2D &amp; obesity, but inter-individual responses vary. Precision medicine &amp; biomarkers guide treatment, though widespread screening may not be cost-effective. #Diabetes #PrecisionMedicine #GLP1R
academic.oup.com/jcem/article/1…
Ivan D. Florez, MD, MSc, PhD (@ivand_florez) 's Twitter Profile Photo

Our paper led by Gordon H. Guyatt on how to address Risk of bias, Publication bias and how to rate up the evidence certainty, as part of the CORE GRADE approach is out in the The BMJ

Sheyu Li (@lisheyusheyu) 's Twitter Profile Photo

Latest data of incidence, prevalence and burden of type 2 diabetes in China - rationale that you should investigate #diabetes #T2DM #epidemiology #China journals.lww.com/cmj/fulltext/9…